Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Fluorine-containing drugs as PET diagnostics (F-18 labeled tracers).

Goodman MM, McConathy J.

Curr Top Med Chem. 2013;13(8):869-70. No abstract available.

PMID:
23590165
2.

Combined (18)F-FDG and fluoride approach in PET/CT imaging: is there a clinical future?

Basu S, Rao R.

J Nucl Med. 2010 Jan;51(1):165; author reply 166-7. doi: 10.2967/jnumed.109.066860. Epub 2009 Dec 15. No abstract available.

3.

Combined (18)F-FDG and fluoride approach in PET/CT imaging: is there a clinical future?

Bailey DL.

J Nucl Med. 2010 Jan;51(1):165-6; author reply 166-7. doi: 10.2967/jnumed.109.066910. Epub 2009 Dec 15. No abstract available.

5.

A comparative uptake study of multiplexed PET tracers in mice with turpentine-induced inflammation.

Huang T, Wang H, Tang G, Liang X, Nie D, Yi C, Wu K.

Molecules. 2012 Nov 26;17(12):13948-59. doi: 10.3390/molecules171213948.

6.

Hybrid PET-dynamic CECT in the management of breast cancer.

Kumar R, Das CJ.

Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):413-5. doi: 10.1007/s00259-008-1055-z. Review. No abstract available.

PMID:
19153731
7.

Assessment of therapy response in lung cancer with ¹⁸F-α-methyl tyrosine PET.

Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Mori M, Endo K.

AJR Am J Roentgenol. 2010 Nov;195(5):1204-11. doi: 10.2214/AJR.09.4167.

PMID:
20966329
8.

[Practice guidelines for PDG-PET cancer screening].

Japanese Society of Nuclear Medicine.

Kaku Igaku. 2004 Nov;41(4):1-21. Japanese. No abstract available.

PMID:
15690769
9.

Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review.

Treglia G, Taralli S, Calcagni ML, Maggi F, Giordano A, Bonomo L.

J Comput Assist Tomogr. 2011 May-Jun;35(3):387-93. doi: 10.1097/RCT.0b013e318219f810. Review.

PMID:
21586936
10.

[Application and future prospect of 18F-FLT PET-CT in guiding delineation of biological target volume].

Han DL, Jiang WR, Yu JM.

Zhonghua Zhong Liu Za Zhi. 2009 Jan;31(1):1-4. Review. Chinese. No abstract available.

PMID:
19538859
11.

123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.

Nguyen NC, Bhatla D, Osman MM.

J Nucl Med. 2010 Feb;51(2):330-1; author reply 331. doi: 10.2967/jnumed.109.069781. Epub 2010 Jan 15. No abstract available.

12.

[Proposal for a diagnostic algorithm for the use of (18)F-FDG-PET in lung cancer].

Borrego-Dorado I, Vázquez-Albertino R.

Rev Esp Med Nucl. 2009 May-Jun;28(3):167-72. Spanish. No abstract available.

13.

Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.

Derlin T, Tóth Z, Papp L, Wisotzki C, Apostolova I, Habermann CR, Mester J, Klutmann S.

J Nucl Med. 2011 Jul;52(7):1020-7. doi: 10.2967/jnumed.111.087452. Epub 2011 Jun 16.

14.

PET for the evaluation of solitary pulmonary nodules.

Fisher RE.

J Nucl Med. 2009 Feb;50(2):326; author reply 326-7. doi: 10.2967/jnumed.108.054031. Epub 2009 Jan 21. No abstract available.

15.

18F-FDG PET/CT imaging in tendon xanthomatosis.

Kim DW, Kim CG, Park SA, Na YC.

Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1403-4. doi: 10.1007/s00259-008-0810-5. Epub 2008 May 20. No abstract available.

PMID:
18491088
16.

Role of positron emission tomography/computed tomography in adrenal and neuroendocrine tumors: fluorodeoxyglucose and nonfluorodeoxyglucose tracers.

Wong KK, Arabi M, Zerizer I, Al-Nahhas A, Rubello D, Gross MD.

Nucl Med Commun. 2011 Sep;32(9):764-81. doi: 10.1097/MNM.0b013e3283478a2a. Review.

PMID:
21799367
17.

[Positron emission tomography/computed tomography with 18F-FDG. PET Working Group. Procedures Committee of the Spanish Society of Nuclear Medicine].

García Garzón JR, Rodríguez A, Cabrera A.

Rev Esp Med Nucl. 2009 Mar-Apr;28(2):85-9. Spanish. No abstract available.

18.

Acute myeloid leukemia detected on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in a patient with fever of unknown origin.

Ozcan Kara P, Kara Gedik G, Sari O, Serdengecti M, Kaya B.

Rev Esp Med Nucl. 2011 Mar-Apr;30(2):115-6. doi: 10.1016/j.remn.2010.07.009. No abstract available.

19.

Striatal "function-metabolism" mismatch on F-18 FDG/F-18 FDOPA PET/CT.

Tripathi M, Sharma R, Jaimini A, Garg G, Khurana A, D'Souza M, Varshney R, Mishra A, Mondal A.

Clin Nucl Med. 2009 Oct;34(10):703-5. doi: 10.1097/RLU.0b013e3181b53a33.

PMID:
19893408
20.

18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.

Vees H, Buchegger F, Albrecht S, Khan H, Husarik D, Zaidi H, Soloviev D, Hany TF, Miralbell R.

BJU Int. 2007 Jun;99(6):1415-20. Epub 2007 Apr 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk